Mar 10, 2026 12:08PM
Feb 25, 2026 02:27PM
Feb 25, 2026 06:22AM
Feb 24, 2026 04:45PM
Jan 23, 2026 07:19AM
Jan 6, 2026 08:18AM
Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026
Dec 9, 2025 04:40AM
Nov 19, 2025 05:23AM
Nov 4, 2025 05:54PM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM
Sep 30, 2025 08:35AM
Sep 12, 2025 05:54AM Goldman Sachs Starts Vaxcyte (PCVX) at Neutral
Aug 8, 2025 08:34AM
Aug 6, 2025 06:22PM
Jun 10, 2025 06:56AM
May 8, 2025 06:22AM
May 1, 2025 08:01AM
Apr 22, 2025 07:22AM
Apr 1, 2025 05:07AM Vaxcyte (PCVX) PT Lowered to $100 at Goldman Sachs
Mar 31, 2025 10:04AM
Mar 31, 2025 08:05AM
Mar 31, 2025 07:00AM
Mar 3, 2025 01:28PM
Feb 24, 2025 05:04AM
Feb 17, 2025 05:38PM
Feb 5, 2025 08:02AM Vaxcyte (PCVX) Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
Dec 20, 2024 06:19AM
Dec 19, 2024 02:00PM
Nov 12, 2024 07:31AM
Nov 6, 2024 06:13AM
Nov 6, 2024 05:59AM
Nov 5, 2024 04:50PM
Oct 24, 2024 12:03PM BTIG Reiterates Buy Rating on Vaxcyte (PCVX)
Oct 10, 2024 08:22AM
Sep 10, 2024 06:37AM
Sep 6, 2024 04:06PM
Sep 5, 2024 06:13AM
Sep 4, 2024 05:27AM
Sep 3, 2024 04:10PM
Sep 3, 2024 04:02PM Vaxcyte (PCVX) Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
Sep 3, 2024 02:42PM
Sep 3, 2024 11:48AM
Sep 3, 2024 09:34AM
Sep 3, 2024 09:33AM
Sep 3, 2024 08:43AM
Sep 3, 2024 08:25AM
Aug 7, 2024 12:15PM BTIG Reiterates Buy Rating on Vaxcyte (PCVX)
Jul 1, 2024 10:42AM

396,355 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All